Brian Shkabari

Brian is a research associate at the Sinclair Cancer Research Institute and Common Sense Oncology. He is a recent graduate of the Bachelor of Health Sciences program at Queen’s University and is a teaching assistant for Dr. Gyawali’s undergraduate course GLPH 488 – Global Oncology: Cancer Care, Policy, Research and Education.

Brian’s research interests are in financial toxicity, global oncology, and cancer policy.

BG Lab Publications:

  1. Shilpakar R, Shkabari B, Acharya B, Lamichhane N, Paudel BD, Yadav M, Sah GS, Poudyal BS, Gyawali B. Availability, Affordability, and Variations in Price of GI Cancer Medicines in Nepal. JCO Glob Oncol. 2025 Nov. PMID: 41232056
  2. Abdihamid O, Gyawali B, Booth CM, Eisenhauer EA, Hopman WM, Shkabari B, Trapani D, Verduzco-Aguirre HC, Wilson BE, Tannock FI*. Adherence of published randomised Phase 3 cancer trials to principles proposed by common-sense oncology. European Journal of Cancer. 2025 Oct. PMID: 41046634.
  3. Wright K, Shkabari B, Booth C, Knopf K, Tregear M, Gyawali B*. Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study. eClinicalMedicine. 2025 Apr. PMID: 40235947.
  4. Raptis SG, Shkabari B, Banday S, Gyawali B. Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries. JCO Oncol Pract. 2025 Jan;21(1):57-68. PMID: 39793549.
Return to Trainees Page